BioCryst Pharmaceuticals Inc (BCRX)
7.58
+0.16
(+2.16%)
USD |
NASDAQ |
Oct 04, 16:00
7.575
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Shareholders Equity (Annual): -455.53M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -455.53M |
| December 31, 2022 | -294.60M |
| December 31, 2021 | -106.99M |
| December 31, 2020 | -19.26M |
| December 31, 2019 | 38.25M |
| December 31, 2018 | 49.24M |
| December 31, 2017 | 83.77M |
| December 31, 2016 | 1.578M |
| December 31, 2015 | 47.72M |
| December 31, 2014 | 75.64M |
| December 31, 2013 | -1.126M |
| December 31, 2012 | -0.454M |
| December 31, 2011 | 14.81M |
| December 31, 2010 | 65.50M |
| December 31, 2009 | 86.27M |
| Date | Value |
|---|---|
| December 31, 2008 | 46.43M |
| December 31, 2007 | 64.91M |
| December 31, 2006 | 21.16M |
| December 31, 2005 | 58.44M |
| December 31, 2004 | 29.33M |
| December 31, 2003 | 28.45M |
| December 31, 2002 | 40.13M |
| December 31, 2001 | 56.81M |
| December 31, 2000 | 61.48M |
| December 31, 1999 | 71.40M |
| December 31, 1998 | 27.70M |
| December 31, 1997 | 25.30M |
| December 31, 1996 | 35.40M |
| December 31, 1995 | 11.30M |
| December 31, 1994 | 11.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-455.53M
Minimum
2023
38.25M
Maximum
2019
-167.62M
Average
-106.99M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Novavax Inc | -716.93M |
| AIM ImmunoTech Inc | 10.23M |
| Perspective Therapeutics Inc | 75.18M |
| Protalix BioTherapeutics Inc | 33.57M |
| Armata Pharmaceuticals Inc | -32.06M |